Market Closed -
OTC Markets
01:27:02 10/05/2024 am IST
5-day change
1st Jan Change
0.337
USD
-3.96%
-1.26%
+100.60%
Presentation Operator MessageOperator (Operator)Greetings. Welcome to the BioLargo Third Quart...
This article is reserved for subscribers
Signed up already?
Log In Not subscribed yet?
Subscribe
Transcript : BioLargo, Inc., Q4 2023 Earnings Call, Apr 02, 2024
03/04
BioLargo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
02/04
CI
Biolargo Equipment Solutions & Technologies, Inc Appoints Sally Gutierrez to the Board of Directors
12/02
CI
BioLargo, Inc. Launches Water Equipment Subsidiary to Capitalize on Opportunities in PFAS and Water Treatment
29/01
CI
BioLargo, Inc. announced that it has received $0.815 million in funding
23/01
CI
BioLargo's PFAS Removal Technology Lands Drinking Water Treatment Project in New Jersey
20/12
CI
BioLargo, Inc. cancelled the transaction announced on December 13, 2022
13/12
CI
Transcript : BioLargo, Inc., Q3 2023 Earnings Call, Nov 20, 2023
21/11
BioLargo, Inc. announced that it expects to receive $0.815 million in funding
17/11
CI
BioLargo, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
14/11
CI
Transcript : BioLargo, Inc., Q2 2023 Earnings Call, Aug 16, 2023
17/23/17
BioLargo, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
15/23/15
CI
Transcript : BioLargo, Inc., Q1 2023 Earnings Call, May 18, 2023
19/23/19
BioLargo, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
17/23/17
CI
Transcript : BioLargo, Inc., 2022 Earnings Call, Apr 03, 2023
04/23/04
BioLargo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
01/23/01
CI
BioLargo, Inc. Auditor Raises 'Going Concern' Doubt
31/23/31
CI
Biolargo, Inc. Announces Revenue Results for the Year 2022
09/23/09
CI
BioLargo, Inc. announced that it expects to receive $10 million in funding from Lincoln Park Capital, LLC
13/22/13
CI
Biolargo, Inc. Announces That the Pooph Pet Odor Control Product Line Is Now Available At Select Walmart Stores
22/22/22
CI
Transcript : BioLargo, Inc., 2022 Earnings Call, Nov 16, 2022
17/22/17
BioLargo, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
15/22/15
CI
Biolargo, Inc. Announces Board and Committee Changes
03/22/03
CI
BioLargo Reports Preliminary Revenue Results for the Third Quarter of 2022
26/22/26
CI
Biolargo Secures Product Recovery Management as Channel Partner and Contract Manufacturer for Biolargos Water Treatment Technologies
06/22/06
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
BioLargo, Inc. is a cleantech and life sciences innovator and engineering services solution provider. The Company invents, develops, and commercializes platform technologies to solve challenging environmental problems like polyfluoroalkyl substances (PFAS) contamination, advanced water and wastewater treatment, industrial odor control, air quality control, infection control, and myriad environmental remediation challenges. The Companyâs segments include ONM Environmental, which manufactures and sells its odor and VOC control products and services, including its flagship product, CupriDyne Clean; BLEST, which provides professional engineering services supporting its internal business units; Clyra Medical, which develops and sells medical products based on its technology; BioLargo Canada, which is primary engaged in research and development activities; and Corporate Operations, which support the operating segments with legal, accounting, human resources, and other services.
More about the company
Last Close Price
0.337
USD
Average target price
0.35
USD
Spread / Average Target
+3.86%
Consensus
1st Jan change
Capi.
+100.60% 99.75M +6.15% 105B -4.19% 63.99B +51.90% 43.02B +17.59% 39.28B +6.89% 33.09B +12.40% 20.23B +16.25% 17.39B +20.35% 15.45B +9.86% 15.07B
Other Commodity Chemicals
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1